• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心力衰竭患者血浆氨基末端前 A 型、B 型和 C 型利钠肽水平与纽约心脏协会(NYHA)心功能分级及超声心动图得出的心脏功能参数的相关性]

[Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].

作者信息

Zhao Xue-yan, Yang Yue-jin, Zhang Jian, Kang Lian-ming, Wei Bing-qi, Gao Xiao-jin, Lü Rong, Zhang Chun-ling

机构信息

Department of Cardiology, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jun;37(6):486-90.

PMID:19927626
Abstract

OBJECTIVE

To observe the correlation of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide (NT-proANP, NT-proBNP and NT-proCNP) levels with New York Heart Association (NYHA) functional class and echocardiographic derived parameters of cardiac function in heart failure patients.

METHODS

Data of NYHA grade, echocardiographic derived parameters of cardiac function, plasma levels of NT-proANP, NT-proBNP and NT-proCNP (measured by enzyme immunoassay method) were obtained in 112 heart failure patients and 44 normal control subjects. The correlation analysis was made between NT-proANP, NT-proBNP, NT-proCNP and NYHA functional class, left atrium diameter (LAD), left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF), respectively.

RESULTS

The plasma concentrations of NT-proANP, NT-proBNP and NT-proCNP in heart failure patients were significantly higher than in control group (all P<0.05). Correlation analysis revealed a strong correlation between NT-proANP and NT-proBNP (r = 0.790, P = 0.000) and a weak correlation between NT-proCNP and NT-proBNP (r = 0.278, P = 0.003) as well as between NT-proCNP and NT-proANP (r = 0.236, P = 0.012) in heart failure patients. Univariant analysis showed that NT-proANP and NT-proBNP were positively correlated to LAD, LVEDD and negatively correlated to LVEF (all P<0.05) while there was no significant correlation between NT-proCNP and echocardiographic derived parameters of cardiac function in heart failure patients. Multivariate stepwise regression analysis including age, gender, NYHA classification, LAD, LVEDD and LVEF revealed that NYHA classification, LVEF, LAD and age were independent predictors of NT-proANP; while NYHA classification, LVEF and age were independent predictors of NT-proBNP while there was no association among these factors and NT-proCNP.

CONCLUSION

In heart failure patients, the plasma concentration of NT-proANP, NT-proBNP and NT-proCNP were significantly increased and NT-proANP, NT-proBNP but not NT-proCNP were significantly correlated to NYHA classification and echocardiographic derived parameters of cardiac function.

摘要

目的

观察心力衰竭患者血浆氨基末端前 A 型、B 型和 C 型利钠肽(NT-proANP、NT-proBNP 和 NT-proCNP)水平与纽约心脏协会(NYHA)心功能分级及超声心动图测定的心脏功能参数之间的相关性。

方法

获取 112 例心力衰竭患者和 44 例正常对照者的 NYHA 分级、超声心动图测定的心脏功能参数、血浆 NT-proANP、NT-proBNP 和 NT-proCNP 水平(采用酶免疫分析法测定)。分别对 NT-proANP、NT-proBNP、NT-proCNP 与 NYHA 心功能分级、左心房内径(LAD)、左心室舒张末期内径(LVEDD)和左心室射血分数(LVEF)进行相关性分析。

结果

心力衰竭患者血浆 NT-proANP、NT-proBNP 和 NT-proCNP 浓度显著高于对照组(均 P<0.05)。相关性分析显示,心力衰竭患者中 NT-proANP 与 NT-proBNP 之间存在强相关性(r = 0.790,P = 0.000),NT-proCNP 与 NT-proBNP 之间以及 NT-proCNP 与 NT-proANP 之间存在弱相关性(r = 0.278,P = 0.003;r = 0.236,P = 0.012)。单因素分析表明,NT-proANP 和 NT-proBNP 与 LAD、LVEDD 呈正相关,与 LVEF 呈负相关(均 P<0.05),而心力衰竭患者中 NT-proCNP 与超声心动图测定的心脏功能参数之间无显著相关性。多因素逐步回归分析纳入年龄、性别、NYHA 分级、LAD、LVEDD 和 LVEF 后显示,NYHA 分级、LVEF、LAD 和年龄是 NT-proANP 的独立预测因素;NYHA 分级、LVEF 和年龄是 NT-proBNP 的独立预测因素,而这些因素与 NT-proCNP 之间无关联。

结论

在心力衰竭患者中,血浆 NT-proANP、NT-proBNP 和 NT-proCNP 浓度显著升高,且 NT-proANP、NT-proBNP 与 NYHA 分级及超声心动图测定的心脏功能参数显著相关,而 NT-proCNP 与上述指标无显著相关性。

相似文献

1
[Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].[心力衰竭患者血浆氨基末端前 A 型、B 型和 C 型利钠肽水平与纽约心脏协会(NYHA)心功能分级及超声心动图得出的心脏功能参数的相关性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jun;37(6):486-90.
2
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.
3
[Peak oxygen consumption, NT-proBNP and echocardiographic changes in patients with chronic heart failure].[慢性心力衰竭患者的峰值耗氧量、N末端B型利钠肽原及超声心动图变化]
Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Mar;43(3):206-11.
4
A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.对利钠肽进行直接比较及其与推测为非缺血性起源的慢性心力衰竭患者生存率的关系。
Eur J Heart Fail. 2005 Jun;7(4):557-65. doi: 10.1016/j.ejheart.2004.06.004.
5
The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP.左心室辅助装置植入治疗终末期心力衰竭患者的利钠肽时间过程:重点关注 NT-proCNP。
Peptides. 2012 Aug;36(2):192-8. doi: 10.1016/j.peptides.2012.05.018. Epub 2012 Jun 5.
6
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.混杂因素在慢性心力衰竭患者中段心房利钠肽分析中的影响
Int J Cardiol. 2016 Sep 15;219:84-91. doi: 10.1016/j.ijcard.2016.05.006. Epub 2016 May 14.
7
Combination of cardiac color Doppler ultrasound, serum MR-ProANP and NT-ProBNP forecasted hypertensive LVH and LFH.心脏彩色多普勒超声联合血清 MR-ProANP 和 NT-ProBNP 预测高血压左心室肥厚和左心房扩大。
Biotechnol Genet Eng Rev. 2024 Nov;40(3):2643-2657. doi: 10.1080/02648725.2023.2200626. Epub 2023 Apr 11.
8
Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.中段心房利钠肽原是检测冠心病患者左心室功能受损的有用指标。
Int J Cardiol. 2008 Aug 18;128(2):244-9. doi: 10.1016/j.ijcard.2007.04.113. Epub 2007 Jul 27.
9
[Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].[心血管疾病患者血清N末端脑钠肽前体水平的变化及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):866-9.
10
[Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].[血浆脑钠肽前体浓度在小儿室间隔缺损合并充血性心力衰竭中的诊断价值]
Zhonghua Er Ke Za Zhi. 2005 Mar;43(3):161-4.

引用本文的文献

1
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.B 型利钠肽与氨基末端 pro-B 型利钠肽:在肾功能受损患者中选择最佳心力衰竭标志物。
BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.